Genome Medical Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
82
- Latest Deal Type
-
Series D
- Investors
-
23
Genome Medical General Information
Description
Operator of a genomic medicine delivery company intended to bridge the gap between genome technology and current medical practice. The company connects individuals and health care providers to genetic experts, providing a genetic assessment to individuals regarding the benefits of testing and creating a personalized clinical action plan, enabling patients to make informed treatment decisions at low costs and medical practitioners to accelerate disease diagnosis.
Contact Information
Website
www.genomemedical.comCorporate Office
- 611 Gateway Boulevard
- Suite 120
- South San Francisco, CA 94080
- United States
Corporate Office
- 611 Gateway Boulevard
- Suite 120
- South San Francisco, CA 94080
- United States
Genome Medical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC (Series D) | 10-Sep-2024 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series C) | 25-Aug-2021 | Completed | Generating Revenue | |||
| 6. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 5. Early Stage VC (Series B) | 23-Jul-2020 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Oct-2018 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A1) | 22-Dec-2017 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 12-Apr-2017 | $10M | $12M | Completed | Generating Revenue | |
| 1. Seed Round | 01-Nov-2016 | $2M | $2M | Completed | Startup |
Genome Medical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A1 | ||||||||
| Series A | ||||||||
| Seed | 4,251,063 | $0.000100 | $0.03 | $0.53 | $0.53 | 1x | $0.53 | 3.09% |
| Series AA | 12,926,897 | $0.000100 | $0.1 | $1.67 | $1.67 | 1x | $1.67 | 9.4% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Genome Medical Comparisons
Industry
Financing
Details
Genome Medical Competitors (19)
One of Genome Medical’s 19 competitors is InformedDNA, a Venture Capital-Backed company based in Saint Petersburg, FL.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| InformedDNA | Venture Capital-Backed | Saint Petersburg, FL | ||||
| InterpretOmics | Formerly VC-backed | Bangalore, India | ||||
| Blueprint Genetics | Formerly VC-backed | Espoo, Finland | ||||
| My Gene Counsel | Venture Capital-Backed | Branford, CT | ||||
| Helix (Laboratory Services (Healthcare)) | Venture Capital-Backed | San Mateo, CA |
Genome Medical Patents
Genome Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230386620-A1 | Systems and methods for detection of potential medical conditions | Inactive | 27-May-2022 | ||
| US-D800741-S1 | Display screen or portion thereof with graphical user interface | Active | 25-Mar-2016 | ||
| US-D800742-S1 | Display screen or portion thereof with graphical user interface | Active | 25-Mar-2016 | ||
| US-D800743-S1 | Display screen or portion thereof with graphical user interface | Active | 25-Mar-2016 | ||
| US-D800750-S1 | Display screen or portion thereof with graphical user interface | Active | 25-Mar-2016 |
Genome Medical Signals
Genome Medical Investors (23)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Amgen Ventures | Corporate Venture Capital | Minority | ||
| Edge (Onalaska) | Corporate Venture Capital | Minority | ||
| GV | Corporate Venture Capital | Minority | ||
| iSelect Fund | Venture Capital | Minority | ||
| Alumni Ventures | Venture Capital | Minority |
Genome Medical Acquisitions (1)
Genome Medical’s most recent deal was a Merger/Acquisition with GeneMatters. The deal was made on 30-Aug-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| GeneMatters | 30-Aug-2021 | Merger/Acquisition | Other Healthcare Services |
Genome Medical FAQs
-
When was Genome Medical founded?
Genome Medical was founded in 2016.
-
Where is Genome Medical headquartered?
Genome Medical is headquartered in South San Francisco, CA.
-
What is the size of Genome Medical?
Genome Medical has 82 total employees.
-
What industry is Genome Medical in?
Genome Medical’s primary industry is Clinics/Outpatient Services.
-
Is Genome Medical a private or public company?
Genome Medical is a Private company.
-
What is Genome Medical’s current revenue?
The current revenue for Genome Medical is .
-
How much funding has Genome Medical raised over time?
Genome Medical has raised $120M.
-
Who are Genome Medical’s investors?
Amgen Ventures, Edge (Onalaska), GV, iSelect Fund, and Alumni Ventures are 5 of 23 investors who have invested in Genome Medical.
-
Who are Genome Medical’s competitors?
InformedDNA, InterpretOmics, Blueprint Genetics, My Gene Counsel, and Helix (Laboratory Services (Healthcare)) are some of the 19 competitors of Genome Medical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process